Stoke Therapeutics, Inc. (STOK) ownership: insiders 7% · institutions 112% · index and ETF funds 6% (13F 2026-03-31). Insider activity, 90 days: 13 sales, 0 open-market buys. SEC EDGAR first-party data.
| Holder | Shares | Market Value | % Outstanding | Reported |
|---|---|---|---|---|
| RTW Investments, LP | 5623525.00 | $183.10M | 9.0% | 2026-03-31 |
| BlackRock | 5385714.00 | $175.36M | 8.6% | 2026-03-31 |
| FMR (Fidelity) | 5383666.00 | $175.29M | 8.6% | 2026-03-31 |
| Lynx1 Capital Management LP | 4763673.00 | $155.11M | 7.6% | 2026-03-31 |
| Redmile Group, LLC | 4164120.00 | $135.58M | 6.7% | 2026-03-31 |
| Morgan Stanley | 3423280.00 | $111.46M | 5.5% | 2026-03-31 |
| Baker BROS. Advisors LP | 3336697.00 | $108.64M | 5.4% | 2026-03-31 |
| TD Asset Management | 3247658.00 | $105.74M | 5.2% | 2026-03-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-08-14 | |
| Sell | null | 2026-08-14 | |
| Sell | null | 2026-08-14 | |
| Sell | null | 2026-08-14 | |
| Sell | null | 2026-08-14 | |
| Sell | null | 2026-08-14 | |
| Sell | null | 2026-08-14 | |
| Sell | null | 2026-08-14 |
Back to STOK overview · STOK earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.